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 From October 2001 until January 2002 captive wild white-tailed deer 
(Odocoileus virginianus) held at the University of Georgia Daniel B. Warnell 
School of Forest Resources Whitehall Deer Research Facility were immobilized 
with a combination of carfentanil (carfentanil citrate) and xylazine (xylazine 
hydrochloride) to 1) determine and evaluate an optimum and safe dose for 
carfentanil/xylazine in white-tailed deer and 2) compare immobilization 
parameters and physiological effects of carfentanil/xylazine to Telazol®/xylazine.  
Animals were given intramuscular injections of 10 mg of xylazine and one of four 
different levels of carfentanil 0.5, 1.0, 1.5, and 2.0 mg.  A carfentanil dose of 1.2 
mg (mean  = 23.0 µg/kg) and 10 mg xylazine (mean = 0.19 mg/kg) was selected 
to compare with a combination of 230 mg of Telazol® (mean = 4.41 mg/kg) and 
120 mg xylazine (mean = 2.3 mg/kg) based on induction times and previously 
published reports.  Time until first drug effects and time until deer dropped to the 
ground without rising were significantly longer in deer treated with 
carfentanil/xylazine than Telazol®/xylazine (p<0.01). Hyperthermia was common 
in deer immobilized with carfentanil, but heart rate, respiration rate, and 
hemoglobin saturation were within acceptable levels.  Quality of anesthesia of 
deer immobilized with Telazol®/xylazine was superior to deer immobilized with 
carfentanil/xylazine.  The combination of 120 mg of naltrexone and 6.5 mg of 
yohimbine provided rapid and complete reversal (mean = 1.9 min.) of 
carfentanil/xylazine immobilization.  Animals immobilized with  
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Telazol®/xylazine had long recovery times with occasional resedation after 
antagonism with 6.5 mg of yohimbine. The combination of carfentanil and 
xylazine at the doses tested did not provide reliable induction or immobilization 
of white-tailed deer even though drug reversal was rapid and safe using 
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INTRODUCTION, JUSTIFICATION, AND OBJECTIVES 
 The research and management of white-tailed deer (Odocoileus 
virginianus) often requires capture of live animals using chemical immobilization.  
Physical restraint by hand or with chute systems is usually not possible in field 
research, and increases the risk of injury to animals and personnel.  In addition, 
some procedures may require a completely anesthetized animal to prevent 
unnecessary discomfort or stress. 
Several criteria must be met for effective and efficient chemical 
immobilization.  An ideal capture drug must be safe.  Although researchers try to 
use caution in field situations, accidents from excitement, inexperience, and 
unstable darting conditions may result in accidental human exposure.  Second, an 
ideal capture drug should have a short induction time.  Short induction times limit 
flight distance, which increases the likelihood of recovering the animal and 
reduces the chance of negative interactions with the public when capture 
situations occur near urban/suburban areas.  Third, an ideal capture drug should 
have a wide safety margin.  It is difficult to assess the size and condition of an 
animal and prepare the proper drug dose in a field situation.  Fourth, an ideal 
capture drug should have no long-term effects.  Chemical immobilization should 
not affect an animal’s long-term behavior or future health.  Fifth, an ideal capture  
drug should be deliverable in a small volume.  Low volumes reduce the time a 
dart must stay in an animal for complete delivery of the drug.  Low volumes also  
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reduce the weight of a dart, which reduces chance of penetration injuries or 
broken bones at the injection site.  Lighter darts are also ballistically superior to 
heavy darts for remote injection.  Sixth, an ideal capture drug should be 
completely reversible.  Following handling, animals must be returned to the wild 
in a fully coordinated and alert state.  Residual drug effects may increase 
mortality through predation, adverse environmental conditions, or intraspecific 
fighting.  Finally, an ideal capture drug should not be cost prohibitive.   At this 
time, there are no published reports of a capture drug for white-tailed deer that 
meets all of these criteria.   
The most commonly used drug combination for remote immobilization of 
wild white-tailed deer is Telazol (tiletamine and zolazepam) and xylazine 
(xylazine HCl) (Kreeger, 1996; Kilpatrick and Spohr, 1999).  The combination of 
Telazol and xylazine has been very effective and safe in field conditions 
(Kilpatrick and Spohr, 1999; Murray et al., 2000).  Drug reversals, however, may 
require an extended recovery time for animals (Millspaugh et al., 1995; Nielsen, 
1999).   
Carfentanil (carfentanil citrate), an ultra-potent opioid, combined with 
xylazine has shown potential for chemical immobilization of cervids.  This 
combination has demonstrated short induction times, wide safety margins, and 
low volumes in some species (Kock and Berger, 1987; Haigh 1991; Miller et al.,  
1996).  Furthermore, it is rapidly and completely reversible with naltrexone 
(naltrexone HCl) and yohimbine (yohimbine HCl) (Meuleman et al., 1984; Haigh, 
1991; Miller et al., 1996).   
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This study 1) determined and evaluated an optimum and safe dose for 
carfentanil/xylazine in white-tailed deer and 2) compared immobilization 





 Hall et al. (1953) described some of the first injectable chemical 
immobilizing agents and equipment for cervids.   They tested curare (d-
tubocurarine hydrochloride pentahydrate) and Flaxedil (tri-(diethylaminoethoxy) 
benzene triethyliodide).  Both were effective for immobilizing deer, but had 
serious limitations for use in the field.  Curare, one of the first immobilization 
drugs, had such a narrow safety margin that slight miscalculation of animal 
weights resulted in death.  Flaxedil, a synthetic curare, did not exert its 
maximum paralytic effect for 20-40 minutes.  There have been tremendous 
advances in immobilizing drugs and remote delivery equipment (Kilpatrick et al., 
1996), but no single drug or combination of drugs is best for all situations or 
species. 
NEUROMUSCULAR BLOCKING DRUGS 
One of the earliest groups of drugs used for chemical immobilization were 
neuromuscular blocking (NMB) drugs.  There are two classes of NMB drugs that 
have been used on cervids: depolarizing and ganglionic.   
Depolarizing NMB drugs 
 The most commonly used depolarizing NMB drug for cervids is 
succinylcholine (succinylcholine chloride).  Succinylcholine depolarizes 
postsynaptic membrane receptors in skeletal muscles, which mimics the 
endogenous neurotransmitter acetylcholine (Kreeger, 1996).  Succinylcholine has  
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no central nervous system (CNS) or analgesic properties.  An animal treated  
with succinylcholine chloride is fully conscious and sensitive to stress, pain, and 
stimulation.  Succinylcholine has a narrow safety margin and is not reversible.  
Pistey and Wright (1961) described the action of succinylcholine in white-tailed 
deer, however, because of major disadvantages, succinylcholine is no longer 
recommended for general use.  
Ganglionic NMB drugs 
The ganglionic class of NMB drugs includes two derivatives of tobacco.  
Nicotine salicylate and nicotine alkaloid cause paralysis by initial stimulation and 
consequent depression of the autonomic ganglia (Nielsen, 1999).  These nicotine 
derivatives have been used to immobilize white-tailed deer (Crockford, 1957; 
Behrend, 1965).  However, several disadvantages have been reported: 1) narrow 
safety margin, 2) nonreversible, 3) rough immobilization, and 4) danger to 
humans (Behrend, 1965; Kreeger, 1996).  Nicotine derivatives are no longer 
recommended for immobilizing any wildlife.  
DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM 
Centrally acting drugs are most commonly used today for chemical 
immobilization work.  This group of drugs depresses or modulates the CNS 
causing sedation to anesthesia (Lumb and Jones, 1996).  There are five classes of 
CNS drugs used in immobilization of cervids:  alpha2-adrenergic agonists, 




  Alpha2-adrenergic agonists are potent CNS depressants with sedative, 
muscle relaxant, and some analgesic properties (Adams, 2001).  Alpha2-agonists 
are commonly used in combination with cyclohexamines or opioids for 
immobilization of white-tailed deer (Klein and Klide, 1989).   The effects of 
alpha2-agonists may last for several hours in white-tailed deer (Hsu and Shulaw, 
1984; Mech et al., 1985).  However alpha2-agonists are reversible. Respiratory 
depression, hyperthermia, and bradycardia have been documented with use of 
alpha2-agonists (Hsu and Shulaw, 1984; Wallingford et al., 1996) 
 Xylazine (xylazine HCl) is one of the most widely used alpha2-agonists.  
Roughton (1975) and Wallingford et al. (1996) used xylazine alone to immobilize 
white-tailed deer caught in box traps and drop-nets, respectively.  However, 
xylazine alone is unreliable for remote immobilization (Roughton, 1975; Hsu and 
Shulaw, 1984).  Xylazine is most commonly used in combination with 
cyclohexamines or opiates and can be used on a wide range of species.   
Overdosing of xylazine may result in respiratory depression (Klein and Klide, 
1989). 
 Detomidine (detomidine HCl) is an alpha2-agonist that was recently 
developed.  It has been used primarily in horses, and is approximately 10 times as 
potent as xylazine in horses (Klein and Klide, 1989).  Galka et al. (1999) describe 
detomidine use in fallow deer (Cervus dama).  In fallow deer, detomidine alone  
caused recumbency with minimal sedation.  Detomidine combined with Telazol  
 
7
caused sufficient anesthesia for surgery (Galka et al., 1999). 
 Medetomidine (medetomidine HCl) is the latest alpha2-agonist approved 
for veterinary use (Neilsen, 1999).  It has a greater affinity and selectivity for the  
alpha2 receptor than the other alpha2-agonists (Jalanka and Roeken, 1990; Klein 
and Klide, 1989).  Jalanka and Roeken (1990) reported that using medetomidine  
alone resulted in incomplete immobilization of captive white-tailed deer. The 
successful use of medetomidine in combination with cyclohexamines has been 
reported for mule deer (Odocoileus hemoinus) and mule deer × white-tailed deer 
hybrids (Caulkett et al. 2000), white-tailed deer (Jalanka and Roeken, 1990), sika 
deer (Cervus Nippon) (Tsuruga et al., 1999; Suzuki et al., 2001), reindeer 
(Rangifer tarandus tarandus) (Ryeng et al., 2001), and fallow deer (Fernandez-
Moran et al., 2000). 
Butyrophenones 
Butyrophenones are neuroleptics with an affinity for the dopamine D-2 
receptor subfamily (Gross, 2001).  They have wide safety margins in normal 
dosages, and cause no substantial negative effects on cardiovascular or 
thermoregulatory systems (Nielsen, 1999).  There are no known antagonists for 
butyrophenones. 
 Azaperone is a butyrophenone that has been used in many European 
countries for nearly 20 years (Gross, 2001).  It is also commonly used in Canada 
and New Zealand.  Azaperone has been used alone and in combination with  
opioids for immobilization of many species.  Wilson et al. (1996a, 1996b)  
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combined azaperone with an alpha2-agonist and an ultra-potent opioid for 
immobilization of red deer (Cervus elaphus) and red × wapiti (Cervus 
canadensis) deer.  De Vos (1978) reports the addition of azaperone can control 
some negative side effects associated with the use of ultra-potent opioids. 
Ultra-potent opioids  
Ultra-potent opioids are CNS drugs characterized by sufficient analgesic 
but limited muscle relaxation properties (Nielsen, 1996).  Opioids are oripavine 
derivatives of the juice of the poppy (Papaver somniferum) or 4-amino-piperidine 
derivatives (Haigh, 1990; Kreeger, 1996).  They bind to specific opioid receptors 
(delta, kappa, mu, sigma) causing CNS modulation and depression (Branson and 
Gross, 2001) They have a wide safety margin, and are reversible.  Ultra-potent 
opioids are very potent, and most animals require only a small volume of drug for 
successful immobilization.  Many are used in combination with alpha2-agonists.   
Major side effects of opioids include: excitability prior to induction, loss 
of thermoregulatory capabilities, respiratory depression, muscle rigidity, 
bradycardia in high doses, vomition, defecation, temporary endocrine changes, 
and potential for narcotic recycling (Haigh, 1990; Kreeger, 1996; Nielsen, 1999). 
Narcotic recycling can occur when the action of an opioid antagonist decreases to 
ineffective levels before the agonist is eliminated from the body, resulting in 
resedation (Roffe et al., 2001).  
 Ultra-potent opioids are extremely potent to humans and should be used  
only if an antagonist is readily available.   Opioids are schedule II narcotics which  
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require a much more extensive application process than other drugs.  The Drug 
Enforcement Administration is the federal agency that reviews all applications 
and issues drug licenses.  
 Etorphine (etorphine HCl) is one of the most commonly used opioids.   
Presnell et al. (1973) found that white-tailed deer given intramuscular injections 
of etorphine (0.02 mg/kg of body weight) and xylazine (0.4 mg/kg) were 
satisfactorily immobilized for up to 90 minutes.  Kreeger et al. (1987) 
immobilized white-tailed deer with intramuscular injections of etorphine only 
(0.05-0.07 mg/kg).  These trials were considered unsuccessful due to long 
induction times characterized by hyperactivity and high mortality rates (two of 
three animals died).  Xylazine (0.5-0.8 mg/kg) was then combined with etorphine 
(0.05-0.07 mg/kg) and injected into additional deer.  This combination resulted in 
complete but not rapid immobilization. Mean (± SD) induction times were 15.7 ± 
2.0 minutes (n = 10). 
 Fentanyl (fentanyl citrate) is an opioid that has been used on many cervid 
species.  It is less potent than etorphine, and the currently available solutions of 
fentanyl are too dilute for larger species (Nielsen, 1999).  Wilson et al. (1996a, 
1996b) evaluated its use on red deer and red × wapiti deer.  A combination of 
xylazine/fentanyl citrate/azaperone was used to effectively immobilize the 
animals, but was not adequate for humane velvet antler removal.  Kocan et al. 
(1981) used fentanyl only to immobilize captive white-tailed deer for collection of  




 Carfentanil (carfentanil citrate) is the most potent opioid available (De 
Vos, 1978; Meuleman et al., 1984; Haigh, 1990).  A derivative of fentanyl, it is 
approximately 10,000 times more potent than morphine in rats and three times  
more potent than etorphine in elk (O’Gara, 1987; Nielsen, 1999).  Carfentanil has 
successfully immobilized ungulates with doses as low as 1.0 µg/kg (Meuleman et 
al., 1984; Bailey et al., 1985).  Carfentanil has demonstrated a wide safety margin 
in some cervids (Bailey et al., 1985; Allen, 1989).  De Vos (1978) used 
carfentanil or carfentanil/xylazine to successfully immobilize 20 species of free-
ranging African herbivores.  Carfentanil also has been used to successfully 
immobilize black bears (Ursus americanus) (Ramsay et al., 1995), polar bears 
(Ursus maritimus) (Haigh et al., 1983), moose (Alces alces) (Meuleman et al., 
1984; Seal et al., 1985; Delvaux et al., 1999; Roffe et al., 2001), elk (Cervus 
elaphus) (Meuleman et al., 1984; Bailey et al., 1985; Haigh, 1991; Miller et al., 
1996), American bison (Bison bison) (Kock and Berger, 1987), wood bison 
(Bison bison athabascae) (Haigh and Gates, 1995), mule deer (Jessup et al., 1984; 
Caulkett et al., 2000), mule deer × white-tailed deer hybrids (Caulkett et al., 
2000), and pronghorns (Antilocapra americana) (O’Gara, 1987).  However, there 
has been no substantial testing of its effectiveness for chemical immobilization of 
white-tailed deer. 
 Thiafentanil (A-3090) is another potent opioid that has been used for  
chemical immobilization of wildlife.  Thiafentanil is approximately 6,000 times 
more potent than morphine (Kreeger et al., 2001).  Thiafentanil alone has been  
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used to immobilize elk (Stanley et al., 1988; Smith et al., 1993) and pronghorns 
(Kreeger et al., 2001).   The addition of xylazine did not demonstrate any 
additional benefit for immobilizing pronghorns (Kreeger et al., 2001).  In elk,  
induction times for thiafentanil are comparable to those of carfentanil, but its 
effects are not as long lasting as those of carfentanil (Stanley et al., 1988).  
Kreeger et al. (2001) reported pronghorns injected with thiafentanil had shorter 
induction times than pronghorns from the same population immobilized with 
carfentanil in an earlier study.  The use of thiafentanil for chemical 
immobilization of white-tailed deer has not been reported. 
Benzodiazepines  
Benzodiazepines are used in combination with other drugs for sedation 
and analgesia.  Normally they will not produce anesthesia when used alone (Hall 
et al., 2001).  Benzodiazepines depress the limbic system and inhibit internuncial 
neurons at spinal levels to induce sedation and muscle relaxation, respectively 
(Hall et al., 2001).  Benzodiazepines have no significant effects on heart rate, 
blood pressure, but may produce minimal cardiovascular depression (Klein and 
Klide, 1989; Nielsen, 1999).  Benzodiazepines are reversible.    
Zolazepam is a benzodiazepine that is combined with tiletamine 
hydrochloride (a cyclohexanone dissociative anesthetic agent) in a 1:1 ratio to 
form Telazol (Haigh et al., 1985; Millspaugh et al., 1995; Kilpatrick and Spohr,  
1999; Murray et al., 2000).  Zolazepam combined with tiletamine improves 
muscle relaxation, counters convulsions often associated with cyclohexane  
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immobilization, and facilitates a smoother induction, with a more uneventful 
recovery (Nielsen, 1999; Murray et al., 2000).  Zolazepam is only sold in 
combination with tiletamine.   
Cyclohexamines  
Cyclohexamines typically produce dissociative anesthesia, analgesia, and 
immobilization in treated animals (Nielsen, 1999).  Cyclohexamines act by 
causing a functional and an electrophysiological dissociation between the 
thalamo-neocortical and limbic systems (Hall et al., 2001).  Cyclohexamines are 
usually used in conjunction with a sedative due to the potential to cause 
convulsions, rough inductions, and rough recoveries when used alone (Kreeger, 
1996).  Cyclohexamines also may cause copious salivation, and a variety of 
hematological, serum chemical, and endocrine alterations (Kreeger, 1996).   
 Phencyclidine (phencyclidine HCl) was the first cyclohexamine used for 
chemical immobilization (Nielsen, 1999).  Dean et al. (1973) described its 
effectiveness for chemical immobilization of captive and free-ranging black-tailed 
deer (Odocoileus hemionus columbianus), mule deer, and white-tailed × black-
tailed hybrids.  Because of illegal human use, it was taken off the market in 1978 
(Nielsen, 1999).   
 Ketamine (ketamine HCl) is a cyclohexane structurally related to 
phencyclidine (Nielsen, 1999). The combination of ketamine and xylazine is  
commonly used for chemical immobilization of white-tailed deer (Kreeger et al., 
1986; DeNicola and Swihart, 1997; Kilpatrick and Spohr, 1999; DelGiudice et al.,  
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2001).  Ketamine is effective for immobilizing white-tailed deer, however it  
requires a large volume that makes remote immobilization difficult (Murray et al., 
2000).  The lyophilized form of ketamine only can be reconstituted to 200 mg/cc  
(Kilpatrick and Spohr, 1999).  A 45.0 kg white-tailed deer requires 297.0 mg of 
ketamine (6.6mg/kg).  Therefore, the combination of ketamine and xylazine 
requires large darts with poor ballistics.  In addition, Kilpatrick and Spohr (1999) 
reported deer darted with ketamine/xylazine traveled greater distances than deer 
darted with Telazol/xylazine.  There are no known antagonists for ketamine. 
   Tiletamine (tiletamine HCl) is a cyclohexanone dissociative anesthetic 
agent that is combined with zolazepam in a 1:1 ratio to form Telazol  (Haigh et 
al., 1985). Telazol has a duration of action approximately three times longer than 
ketamine (Branson, 2001).  In many species, the induction time for Telazol is 
faster than the induction time of ketamine (Millspaugh et al., 1995; Nielsen, 
1999).  Telazol is typically used in combination with xylazine for 
immobilization of white-tailed deer (Millspaugh et al., 1995; Kilpatrick and 
Spohr, 1999; Murray et al., 2000).  Telazol is more highly concentrated than 
ketamine.  The powdered form of Telazol can be reconstituted up to 500mg/cc, 
which is an advantage for remote injection (Kilpatrick and Spohr, 1999).  The 
tiletamine component of Telazol is not reversible, but there is an antagonist for  




 Antagonists are drugs capable of blocking the effects of the agonist 
(Novotny, 2001).  There are antagonists for three classes of immobilizing drugs: 
alpha2-adrenergic agonists, opioids, and benzodiazepines.   
Alpha2-adrenergic antagonists  
Alpha2-adrenergic antagonists are used to reduce the effects of alpha2-
adrenergic agonists that may last several hours in white-tailed deer (Hsu and 
Shulaw, 1984; Mech et al., 1985).  When using an alpha2-adrenergic agonist in 
combination with a cyclohexamine, immediate administration of an alpha2 
antagonist may reveal the negative qualities of the cyclohexamine (Kreeger, 1996; 
Kilpatrick and Spohr, 1999).  Therefore, sufficient time to allow metabolism of 
the cyclohexamine should occur before the administration of the alpha2-
adrenergic antagonist.  
 Nielsen (1999) stated yohimbine (yohimbine HCl) was the first alpha2 
antagonists used for reversal of xylazine.  Yohimbine acts by blocking central and 
peripheral alpha1 and alpha2 receptors (Klein and Klide, 1989).  This permits 
resumption of neural transmission (Nielsen, 1999).  Although newer alpha2 
antagonists have virtually no pharmacological effects when given alone, 
yohimbine has demonstrated behavioral and cardiovascular actions in some 
species (Klein and Klide, 1989).  Successful antagonism of xylazine in white-
tailed deer has occurred with intramuscular injection of yohimbine (Wallingford  
et al., 1996).  However, intravenous injection may provide a more rapid recovery  
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(Mech et al., 1985; Murray et al., 2000).    
Tolazoline (tolazoline HCl) has the least alpha2-adrenoreceptor specificity 
of all the alpha2 antagonists (Kreeger et al., 1986; Nielsen, 1999).  Tolazoline has 
histaminergic activity that has caused negative side effects in some species 
(Kreeger et al., 1986; Dew, 1988; Kreeger, 1996), but tolazoline has been  
effective in antagonizing xylazine in white-tailed deer (Kreeger et al., 1986; Dew, 
1988; DelGuidice et al., 1989).   
 Atipamezole is more potent and selective than tolazoline or yohimbine 
(Jalanka and Roeken, 1990; Arnemo et al., 1993; Kreeger, 1996).  Overdosing of 
atipamezole may cause excitability and overalertness, and underdosing may result 
in resedation (Jalanka and Roeken, 1990; Nielsen, 1999).  Atipamezole is the 
alpha2-antagonist primarily used for reversal of medetomidine because 
medetomidine is a specific agonist.  Ancrenaz (1994) reported atipamezole was 
not able to reverse all of the effects of xylazine immobilization in captive Arabian 
oryx (Oryx leucoryx).  Xylazine affects alpha1-receptors and alpha2-receptors and 
atipamezole is only specific for alpha2-receptors.  However, Arnemo et al. (1993) 
reported complete reversal of xylazine induced immobilization in axis deer (Axis 
axis) with no relapse into sedation, and only one animal of eight showed signs of 
overalertness. Nicholls et al. (1996) reported grey duikers (Sylvicapra grimmia) 
immobilized with ketamine/xylazine showed variable reversal of sedation with 
atipamezole.  Tsuruga et al. (1999) reported the use of atipamezole on sika deer  
immobilized with medetomidine and ketamine resulted in smooth and rapid 
reversal.   
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Opioid antagonists  
  Modern opioid antagonists give researchers the ability to return 
immobilized animals to a normal state with their natural functions and reflexes 
intact (Nielsen, 1996).  Diprenorphine (diprenorphine HCl) and nalorphine 
(nalorphine HCl) are two of the earlier antagonists used to reverse the  
effects of fentanyl and etorphine (Kreeger, 1996; Nielsen, 1999).  Diprenorphine 
and nalorphine act as an antagonist on the mu receptor, while displaying agonistic 
characteristics on other opioid receptors (Haigh, 1990).  Overdosing with these 
drugs may result in continued immobilization (Haigh, 1990).   Use of 
diprenorphine and nalorphine has decreased with the development of new opioid 
antagonists. 
 Naloxone (naloxone HCl), naltrexone (naltrexone HCl), and nalmefene 
(nalmefene HCl) are opioid antagonists with no agonistic properties (Haigh, 1990; 
Kreeger, 1996; Nielsen, 1999).    Nalmefene in a ratio of 100 mg nalmefene : 1 
mg carfentanil has been used successfully to antagonize carfentanil in a variety of 
nondomestic ungulates; however, narcotic recycling was more likely to occur 
with nalmefene than with naltrexone given at the same ratio (Allen, 1989 and 
1996).   
Haigh (1991) reports that a mean ratio of 48.5 mg naloxone : 1 mg 
carfentanil was effective in antagonizing carfentanil induced immobilization in  
elk. Carfentanil induced immobilization in bison and polar bears has also been 
reversed completely by naloxone, but naloxone has a shorter duration of activity  
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than naltrexone and has resulted in higher rates of narcotic recycling in many  
species (Haigh et al., 1983; Bailey et al., 1985; Kock and Berger, 1987; Haigh, 
1991).   
 The reported use of naltrexone in a ratio of 100 mg naltrexone : 1 mg 
carfentanil has demonstrated rapid and complete antagonism of carfentanil in elk,  
black bears, and many nondomestic ungulates (Allen, 1989; Haigh, 1993; Ramsay 
et al., 1995; Allen, 1996; Miller et al., 1996).  A ratio of 125 mg naltrexone : 1 mg 
carfentanil has been effective in antagonizing carfentanil and preventing narcotic 
recycling in moose and wood bison (Haigh and Gates, 1995; Roffe et al., 2001).  
Carfentanil antagonism by naltrexone based on body weight, not dose of 
carfentanil, has been effective in dama gazelles (Gazella dama), moose, mule 
deer, and mule deer × white-tailed deer hybrids (Schumacher et al., 1997; 
Delvaux et al., 1999; Caulkett et al., 2000).   Designating a portion of the 
antagonist for injection either intramuscularly or subcutaneously while delivering 
the rest intravenously may reduce the chance of narcotic recycling (Haigh et al., 
1983; Ramsay et al. 1995; Miller et al., 1996; Delvaux et al., 1999). 
Benzodiazepine antagonists  
Flumazenil is an antagonist that effectively reverses benzodiazepines 
(Nielsen, 1999).  Flumazenil has a great affinity for benzodiazepine receptors and 
reverses all actions of benzodiazepines without any side effects (Lumb and Jones,  
1996).  Recovery time of river otters (Lutra canadensis) immobilized with 
tiletamine/zolazepam (Telazol) was shortened with the use of flumazenil  
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(Spelman et al., 1997).  Anesthesia of babirusa (Babyrousa babyrussa) 
immobilized with xylazine and tiletamine/zolazepam (Telazol) also was reversed 
with the combination of yohimbine and flumazenil (James et al., 1999).  
However, the effectiveness of flumazenil for antagonizing the zolazepam portion 
of Telazol immobilization in white-tailed deer has not been reported. 
 There are many classes of immobilization drugs, each with its own 
positive and negative attributes.  No single drug or drug combination is best for 
all situations or species.  The development of new drugs with fewer negative 









A COMPARISON OF CARFENTANIL/XYLAZINE  
WITH TELAZOL/XYLAZINE FOR  
IMMOBILIZATION OF WHITE-TAILED DEER 
 
MATERIALS AND METHODS 
 All research was conducted at the University of Georgia Daniel B. 
Warnell School of Forest Resources Whitehall Deer Research Facility (33o53’N, 
83 o21’W).  The mean weight (± SD) of tested animals was 52.1 ± 8.7 kg. 
Animals were housed in large outdoor pens with food and water available ad 
libitum.  Deer were moved to three by six meter stalls for 24-36 hours prior to 
treatments.  Food was withheld 12-16 hours before immobilization.   
 Animals were randomly assigned to treatments administered in a squeeze 
chute via intramuscular (IM) injection in the hindquarter.  After drug injection, 
animals were immediately released into a 15x20 m observation pen where 
observers recorded time for first noticeable drug effect (e.g., stumbling, change in 
movement pattern and behavior) and induction time (when deer dropped to the 
ground without rising).  Following lateral recumbency, each deer was moved, 
treated with ophthalmic ointment (Paralube Vet Ointment, Pharmaderm, 
Melville, New York, USA) to prevent corneal drying, masked, and weighed.  
Heart rate (determined by auscultation), respiration rate (observed by thoracic  
movements), rectal temperature (digital thermometer, B-D Digital Fever  
Thermometer, Becton Dickinson, Franklin Lakes, New Jersey, USA), and 
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hemoglobin saturation (pulse oximeter with probe on the tongue, Ohmeda Biox 
3700, Ohmeda, Louisville, Colorado, USA) were recorded at 5-10 and 15-20 
minutes after induction.  The maximum temperature measurable by the 
thermometer was 42.2ºC.  Therefore temperatures ≥ 42.2ºC were recorded as 
42.2ºC.   
Approximately 30 minutes after induction, each animal was taken to an 
individual stall for antagonist administration.  All animals were periodically 
checked for signs of resedation for 24 hours following antagonist administration.  
To avoid arousing any resedated animals, all night checks were made in complete 
darkness with the use of night vision equipment (ITT Night Quest Model 160, 
ITT, Roanoke, Virginia, USA).  Time periods from injection of agonists until 
induction (C/X and T/X treated deer) and time periods from injection of 
antagonist until standing (C/X treated deer) were videotaped for further 
evaluation.  
Regression analysis for general linear models was used to evaluate the 
relationship between induction times, physiological measurements, and 
carfentanil dose.  Relationships between ambient temperatures and rectal 
temperatures were examined by correlation.  Differences between groups were 
analyzed using paired t-tests and the Wilcoxin Signed Rank test for non-normal 
data (SAS Institute, Cary, North Carolina, USA).  If no significant differences  
were detected between time periods, values were combined and used to test for 
differences between drug treatments.   
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Optimization of carfentanil dose   
 Nineteen captive white-tailed deer (> 1.5 yrs old; 10 males, 9 females) 
were immobilized with carfentanil (3 mg/ml; Wildnil, Wildlife Laboratories, 
Inc., Fort Collins, Colorado, USA) and xylazine (Cervizine, Wildlife 
Laboratories, Inc., Fort Collins, Colorado, USA) between 8-31 October 2001. Ten 
of the 19 deer were immobilized on two separate occasions with a three week 
washout period between treatments.  Deer were randomly assigned to one of four 
treatment groups. Four males and four females were given a carfentanil dose of 
0.5, 1.0, or 1.5 mg.  Three males and three females were given a carfentanil dose 
of 2.0 mg.  Each dose of carfentanil was combined with 10 mg xylazine. 
Immobilization was reversed with naltrexone (50 mg/ml, Trexonil, Wildlife 
Laboratories, Inc., Fort Collins, Colorado, USA) administered at 100 times the 
carfentanil dose (Allen, 1996) and 5 mg yohimbine (5 mg/ml, Antagonil, 
Wildlife Laboratories, Inc., Fort Collins, Colorado, USA).  The actual yohimbine 
dosage ranged from 0.08-0.14 mg yohimbine/kg body weight.  After yohimbine 
was given intravenously (IV), naltrexone was given half IV and half 
subcutaneously (SC).  Time from injection of naltrexone until the deer was 
standing was recorded to the nearest second.   
Duration and safety of carfentanil/xylazine effect without antagonist 
treatment 
 Two male and two female deer, > 1.5 yrs old, were immobilized on 22 
January 2002 with 1.2 mg carfentanil and 10 mg xylazine. After induction,  
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physiological measurements were recorded at 5-10 and 15-20 minutes as before, 
and then heart rate, respiration rate, and rectal temperature were taken 
approximately every 30 minutes until the animals were unapproachable.   
Duration of immobilization was recorded as the time from induction until the deer 
was standing.  Ambient temperatures ranged between 10-15 ºC during trials.   
Comparison of carfentanil/xylazine to Telazol/xylazine 
 On 20 December 2001, 16 deer, > 1.5 yrs old were randomly assigned to 
drug treatment groups (eight males and eight females).  Eight deer were 
immobilized with a combination of 1.2 mg of carfentanil (19.9-29.9 µg/kg) and 
10.0 mg of xylazine (0.15-0.25 mg/kg) (C/X) and eight deer were immobilized 
with a combination of 230 mg Telazol (3.4-5.7 mg/kg) (100 mg/ml, Fort Dodge 
Animal Health, Fort Dodge, Iowa, USA) and 120 mg of xylazine (1.8-3.0 mg/kg) 
(T/X).   The drug treatment groups were reversed in each deer 2.5 weeks later. 
Immobilization was reversed using naltrexone (100 times the carfentanil 
dose) combined with 6.5 mg yohimbine in a single syringe for C/X deer, and 6.5 
mg yohimbine for T/X-treated deer.  All reversal drugs were given half IV and 
half SC.  Any T/X-treated deer that showed no signs of reversal after 120 minutes 
were given an additional 10 mg yohimbine (half IV and half IM).  Time of  
reversal was recorded to the nearest second for C/X-treated deer and to the nearest 




Optimization of carfentanil dose  
  A combination of (0.5-2.0 mg) carfentanil (7.75-46.84 µg/kg) and 10 mg 
xylazine (0.16-0.27mg/ kg) was evaluated with 29 immobilizations on 19 deer.  
Time to first noticeable drug effects occurred from 0.7-3.5 minutes and included 
stumbling and changes in gait patterns. Excitability was observed in most 
animals.  Deer ran around the observation pen in circles, often unconcerned or 
unaware of the presence of nearby human observers.   Hind-end ataxia was 
common prior to induction.  Two animals violently flipped on their backs from 
loss of control in the hind legs; however, they suffered no ill effects.  Generalized 
muscle fasciculations lasting 5-10 minutes post induction were common in 
sternally or laterally recumbent animals.  Urination and penile erections were 
observed in males on two occasions. 
Induction times ranged from 2.2-8.7 minutes.  Linear regression of 
carfentanil dose verses induction time was statistically significant (p<0.05). 
However, due to variability of induction times, the linear model was a poor 
predictor of the relationship (r2 =0.17; Fig. 1).  Quality of immobilization was not 
consistent.  Similar doses of carfentanil caused varied levels of sedation.  Some 
animals were completely immobilized while others were responsive to noise or 
touch. 
Carfentanil dose of 1.2 mg (23.0 µg/kg) combined with 10 mg of xylazine 














FIGURE 1.  Induction times of white-tailed deer immobilized with intramuscular  
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induction times, and higher doses did not show improvement in induction times 
(Fig. 1). All reversals were rapid.  Mean (±SD) reversal times were 2.6 ± 1.7  
minutes.  Only one animal showed signs of narcotic recycling.  A female that 
received a carfentanil dose of 34.4 µg/kg appeared drowsy and reluctant to rise 
1.5 hours after reversal.  All other animals appeared alert and fully coordinated 
following antagonist administration.  
One animal sustained a lower lip avulsion after colliding with a fence, and 
required sutures.  Hyperthermia (rectal temperatures ≥ 41.1ºC) was observed in 13 
of 29 immobilizations.  All other physiological parameters were considered 
acceptable.  No health complications resulting from immobilization and reversal 
of C/X were observed in the animals within three months post-immobilization 
treatment.   
Carfentanil/xylazine immobilization without antagonist treatment 
Mean (±SD) duration of immobilization for C/X-treated deer was 3.5 ± 
0.8 hours.  Three to 5 observations per deer were taken during immobilization.  
There was no significant relationship between heart rate (24-66 beats/min), or 
respiration rate (7-30 breaths/min) and duration of immobilization (p>0.05).   
Rectal temperatures were negatively related with duration of immobilization 
(p<0.05) (Fig. 2).  One animal that fractured its mandible during induction was 
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FIGURE 2.  Rectal temperaturesa of white-tailed deer immobilized 

























a  The maximum temperature measurable by the thermometer was 42.2°C.   
 
No observations were recorded until temperatures fell to measurable levels. 
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Comparison of carfentanil/xylazine to Telazol/xylazine 
 All deer injected with C/X or T/X were successfully immobilized.  All 
deer were hand-injected in the squeeze chute except one, this deer was physically  
restrained by two people for injection.  Time until first noticeable drug effect and 
induction time were significantly  (p<0.01) shorter with T/X-treated deer than 
C/X-treated deer (Table 1).   
 Quality of immobilization was not consistent among the 16 C/X-treated 
deer.  One male had to be reversed before all physiological measurements could  
be taken due to an insufficient level of anesthesia.  Four other C/X-treated deer 
were responsive to sound or touch, however all measurements were obtained.  All 
T/X-treated deer demonstrated excellent immobilization.   
Physiological data are presented in Table 2. Respiration rates, heart rates, 
and rectal temperatures did not differ significantly between the two time periods 
measured for C/X-treated deer or T/X-treated deer. Respiration rates and heart 
rates did not significantly differ (p>0.05) between C/X and T/X immobilized deer.  
Rectal temperatures were higher (p<0.01) in C/X-treated deer than T/X-
treated deer.  Nine of 16 deer immobilized with C/X had rectal temperatures ≥ 
41.1ºC; however, only two of 16 deer immobilized with T/X had rectal 
temperatures ≥ 41.1ºC.  No correlation was found between ambient temperature at 
time of agonist injection and rectal temperature 15-20 minutes post induction for 
C/X-treated deer (r=0.08, p>0.05) or T/X-treated deer (r=-0.28, p>0.05).    




Table 1.  Chemical immobilization of 16 white-tailed deer using 1.2 mg carfentanil and 10 mg 
xylazine (C/X) and 230 mg Telazol® and 120 mg of xylazine (T/X) and reversal by 120 mg of 
naltrexone and 6.5 mg of yohimbine (N/Y) and 6.5 mg yohimbine (Y). 
 
Agonist              C/X           T/X 
 
    mean ± SD (n)    mean ± SD (n) 
 
              (range)               (range) 
 
 
Time to first effect (min) 1.8 ± 0.6 (16)    1.4 ± 0.3 (16) 
 
       (0.4-3.0)        (0.9-2.1) 
 
Induction time (min) 4.7 ± 3.3 (16)    2.4 ± 0.7 (16)  
 
       (0.5-11.7)        (1.1-4.6) 
  
 
Antagonist            N/Y              Y 
 
   mean ± SD (n)    mean ± SD (n) 
 
             (range)               (range)             
 
 
Reversal time (min) 1.9 ± 1.1 (16)    165.5 ± 66.4 (13)a 
 
         (0.6-5.0)          (69-259) 
 










Table 2.  Physiological data from 16 white-tailed deer immobilized with 1.2 mg of carfentanil and 
10 mg xylazine (C/X) and 230 mg Telazol® and 120 mg xylazine (T/X). 
 
         C/X           T/X  
   mean ± SD (n)    mean ± SD (n) 
             (range)             (range)      
Time post           
Induction (min)      5-10         15-20      5-10        15-20  
 
Parameter 
SpO2  90.3 ± 3.1 (13)  90.6 ± 4.1(14)  84.5 ± 7.8 (14) 86.9 ± 5.4 (15)    
      (85-95)     (79-95)      (72-94)     (75-92) 
Heart rate 66.6 ± 24.9 (16) 66.6 ± 26.0 (15)  65.5 ± 16.0 (16) 65.9 ± 29.8(16)  
      (40-125)     (40-126)      (48-112)     (40-172)  
Respiration 30.8 ± 22.3 (16) 29.5 ± 27.3 (15)  28.3 ± 22.5 (16) 33.3 ± 30.5 (16)  
Rate      (11-102)       (9-112)        (8-102)       (8-122) 
Rectal   41.1 ± 1.0 (16) a 40.9 ± 1.2 (15)  40.1 ± 1.1 (16) 40.0 ± 1.1 (16)  
temperature (ºC)   (39.3-42.2)   (39.0-42.2)    (38.5-42.2)   (38.6-42.2) 
 






C/X-treated deer (p>0.05), however hemoglobin saturation for T/X-treated deer 
was higher (p<0.05) in the second time period.  Hemoglobin saturation was not 
different (p=0.07) in the first time period between C/X-treated deer and T/X- 
treated deer.  Hemoglobin saturation was higher (p<0.05) in the second time 
period for C/X-treated deer than for T/X-treated deer.   
Reversals of C/X-treated deer were rapid (mean = 1.9 min.), compared to 
reversals of T/X-treated deer (mean = 165.5 min)(Table 1). Due injection errors, 2 
C/X-treated deer did not receive the full subcutaneous dose of naltrexone and 
yohimbine, however reversal times were normal (1.0 and 1.8 min.) and there were  
no signs of narcotic recycling.  Narcotic recycling was not present after antagonist 
administration in any of the C/X-treated deer, however at least five of the sixteen 
T/X-treated deer were found partially or fully immobilized 1-4 hours after initial 
standing.   
One C/X-treated animal sustained a laceration on its leg, and another 
sustained a lower lip avulsion.  Both recovered normally with only superficial  
treatments.  One female injected with T/X ate from a feeder located in the release 
pen before succumbing to drug effects and regurgitated while being carried to a 
stall.  She died 3 weeks later from probable aspiration pneumonia.  No other 
animals exhibited any health complications within one month post treatment. 
DISCUSSION 
The 1.2 mg of carfentanil (19.9-29.9 µg/kg) combined with 10.0 mg of 
xylazine (0.15-0.25 mg/kg) was not reliable for producing short induction times in  
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captive white-tailed deer.  Induction times did not decrease with higher dosages, 
and there was an increased risk of narcotic recycling with higher dosages (Haigh, 
1990).   Additionally, Jessup et al. (1984) reported a mean carfentanil dose of 30.0  
µg/kg was effective for remote immobilization of captive mule deer (Odocoileus 
hemionus) and Caulkett et al. (2000) reported an intramuscular injection of 
carfentanil 10.0 µg/kg was effective for immobilizing captive mule deer and mule 
deer/white-tailed deer hybrids.   
Short induction time is one of the most important characteristics of a 
remote immobilization drug.  The risk of injury and hyperthermia increased with 
prolonged induction times.  In field situations, long induction times increase flight 
distance and reduce the chance of recovering an animal.   
Not all field procedures would be possible when using the tested dosages 
of C/X as an immobilization drug combination for white-tailed deer because of 
variability of drug effect. The level of immobilization in all C/X-treated animals 
was adequate for minimal handling; however, complex or invasive procedures  
would not have been possible in some animals.    
Safe chemical immobilization should not cause adverse effects to normal 
physiological function.  Respiratory depression is a concern with opioids and 
xylazine (Klein and Klide, 1989; Haigh, 1990).  However, hemoglobin saturation 
was not different in the first time period between C/X-treated deer and T/X-
treated deer, although it was almost significantly higher for C/X-treated deer 
(p=0.07), and hemoglobin saturation for C/X-treated deer was significantly higher  
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than T/X-treated deer in the second time period.  Hyperthermia was common in 
C/X-treated deer.  C/X should only be used to immobilize white-tailed deer if 
adequate means to decrease body temperature are available.  Heart rates and  
respiratory rates were considered acceptable for C/X-treated deer.   
Jessup et al. (1984) reported rectal temperatures, heart rate, respiration 
rate, and blood pressure of a mule deer increased to unsafe levels as duration of 
carfentanil immobilization increased.  Because some animals immobilized in the 
field are not recovered, the relationships between certain physiological parameters 
and duration of immobilization were investigated.   Since no relationship between 
heart rates or respiration rates and duration of immobilization was found, and 
rectal temperatures returned to normal as duration of immobilization increased, 
the recovery from C/X immobilization, using the dosages investigated, without 
reversal does not increase the risks associated with carfentanil in white-tailed 
deer. 
Immobilization with carfentanil/xylazine is effectively and rapidly  
reversed using naltrexone and yohimbine in white-tailed deer.  Animals were alert 
and fully coordinated within minutes of antagonist administration, with little risk 
of renarcotization.  This ability to completely reverse immobilization may be 
extremely beneficial in field situations. 
The combination of Telazol® and xylazine also effectively immobilized 
white-tailed deer.  Induction times were rapid, and immobilization was excellent 
for all animals.  In addition, all physiological parameters remained satisfactory. 
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Reversal times for deer immobilized with the combination of Telazol® and 
xylazine were prolonged.  The sluggish and uncoordinated demeanor of animals 
after yohimbine administration suggested residual xylazine effects. The 0.125  
mg/kg yohimbine dose recommended by Kreeger (1996) appeared to 
insufficiently antagonize the effects of xylazine.   
Immobilization drugs should not be cost prohibitive.  Costs to immobilize 
animals with 1.2 mg of carfentanil and 10 mg of xylazine were $15.05 per animal.  
Reversal using 120 mg of naltrexone and 6.5 mg of yohimbine was $23.33 per 
animal.  Therefore, total cost per deer was $38.38.  Immobilization with 230 mg 
of Telazol® and 120 mg of xylazine was $12.08 per animal.  Reversal with 6.5 mg 
of yohimbine was $2.93 per deer.  Therefore, total cost was $15.01 per deer.  
Although use of carfentanil and xylazine to immobilize deer, and its reversal with 
naltrexone and yohimbine was more than twice the cost of the other treatment, the 
ability to rapidly reverse immobilization may increase the number of possible 
immobilizations each day and reduce overall costs.   
Major drawbacks for the use of carfentanil are its risk to human personnel 
and its classification as a schedule II narcotic.  Carfentanil is extremely toxic to 
humans and should never be used in the absence of a syringe containing an 
emergency antagonist.  All ultra-potent opioids are classified as schedule II 
narcotics.  The Drug Enforcement Administration requires strict license and usage 
requirements for schedule II narcotics.   
Additional dose evaluations of carfentanil and xylazine should be  
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conducted to reduce induction times and improve reliability of anesthesia in 
white-tailed deer.  Furthermore, research of yohimbine and other alpha-2 
antagonists and benzodiazepam antagonists should be conducted to decrease the  
long recovery times associated with Telazol® and xylazine immobilization. 
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 The combination of carfentanil (carfentanil citrate) and xylazine (xylazine 
hydrochloride) has been an effective drug combination in cervids.  However this 
study demonstrated that the combination of 23.0 µg/kg of carfentanil and 10.0 mg 
of xylazine (C/X) was not effective for rapid induction and immobilization of 
white-tailed deer.  Inductions were prolonged in some animals.  Animals with 
long induction times have an increased risk of injury or hyperthermia, or not 
being found in field settings. 
Quality of immobilization was variable for animals treated with C/X.  
Some animals given similar doses displayed very different levels of anesthesia.  
Most measured physiological parameters for animals immobilized with C/X were 
within acceptable levels.  However, hyperthermia was common in animals 
immobilized by C/X.   
 Reversal of C/X immobilization with naltrexone (naltrexone 
hydrochloride) and yohimbine (yohimbine hydrochloride) was rapid and 
complete.  Narcotic recycling was not common in white-tailed deer immobilized 
with C/X.   
 Carfentanil’s complete reversibility, and low volume make it an attractive 
drug for remote immobilization of white-tailed deer.  However, additional 
research evaluating doses of carfentanil and xylazine is necessary before C/X can 
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